The past, present, and future of immunotherapy for endometrial adenocarcinoma-Reference-Cited by-同舟云学术

The past, present, and future of immunotherapy for endometrial adenocarcinoma

Published:2023-05-23 Issue:7 Volume:40 Page:
ISSN:1559-131X
Container-title:Medical Oncology
language:en
Short-container-title:Med Oncol

Author:

Jones Anna C.,Brown Karah H.,Guan Tianyun,Smith Luke A.,Formslag Cole R.,Farjado Emerson D.,Bai Qian,Luechtefeld Harrison D.,Wakefield Mark R.,Dong Lijun,Fang Yujiang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Hematology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s12032-023-02040-7.pdf

Reference48 articles.

1. Crosbie EJ, Kitson SJ, McAlpine JN, Mukhopadhyay A, Powell ME, Singh N. Endometrial cancer. Lancet. 2022;399(10333):1412–28. https://doi.org/10.1016/S0140-6736(22)00323-3. (PMID: 35397864).

2. Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics. CA Cancer J Clin. 2023;73(1):17–48. https://doi.org/10.3322/caac.21763. (PMID: 36633525).

3. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 1983;15(1):10–7. https://doi.org/10.1016/0090-8258(83)90111-7. (PMID: 6822361).

4. Feinberg J, Albright B, Black J, Lu L, Passarelli R, Gysler S, Whicker M, Altwerger G, Menderes G, Hui P, Santin AD, Azodi M, Silasi DA, Ratner ES, Litkouhi B, Schwartz PE. Ten-year comparison study of type 1 and 2 endometrial cancers: risk factors and outcomes. Gynecol Obstet Invest. 2019;84(3):290–7. https://doi.org/10.1159/000493132. (PMID: 30602164).

5. Cancer Genome Atlas Research Network, Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, Robertson AG, Pashtan I, Shen R, Benz CC, Yau C, Laird PW, Ding L, Zhang W, Mills GB, Kucherlapati R, Mardis ER, Levine DA. Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67–73. https://doi.org/10.1038/nature12113.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Editorial: Dual role of inflammatory mediators in cancer immunotherapy;Frontiers in Immunology;2023-07-31